Diabetic Retinopathy

PANORAMA – Sponsored by Regeneron Pharmaceuticals, Inc.

Active Study | Duration: 103 weeks

PANORAMA was a multicenter, double-masked, randomized Phase III clinical trial for the treatment of Non-Proliferative Diabetic Retinopathy (NPDR). This study... Read More

RUBY – Sponsored by Regeneron Pharmaceuticals, Inc.

Completed Study | Duration: 36 weeks

RUBY REGN910-3 was a multi-center, prospective, and randomized Phase II clinical trial for the treatment of Diabetic Macular Edema (DME). It compared the efficacy of... Read More

ALLEGRO PVD – Sponsored by Allegro Ophthalmics, LLC

Completed Study | Duration: 90 days

ALLEGRO PVD is a multi center, prospective, randomized, and placebo-controlled Phase II clinical trial for the induction of Posterior Vitreous Detachment (PVD). There... Read More

ALLEGRO DME – Sponsored by Allegro Ophthalmic, LLC

Completed Study | Duration: Six months

ALLEGRO DME was a multi center, prospective, and randomized Phase II clinical trial for the treatment of Diabetic Macular Edema (DME). It compared the efficacy of... Read More

DRCR – Sponsored by Diabetic Retinopathy Clinical Research Network

Completed Study

Intravitreal triamcinolone acetonide injections and Laser Photocoagulation in the treatment of Diabetic Macular Edema... Read More

FAME - Sponsored by Alimera Sciences

Completed Study | Duration: 36 months

Iluvien® is an extended release intravitreal insert developed for the treatment of Diabetic Macular Edema. During the trial, Iluvien® demonstrated a significant effect... Read More

Allergan DME Laser 206207-012 – Sponsored by Allergan Pharmaceuticals

Completed Study

Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in combination with laser versus laser alone in the treatment of Diabetic Macular Edema. Read More

Connect

Loading ...

Ophthalmologist Website Design | Accessibility Policy
Washington DC Diabetic Retinopathy | Diabetic Retinopathy Treatment in Maryland | Virginia Diabetic Retinopathy